跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RIVA-TADALAFIL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RIVA-TADALAFIL
Authorized
STANDARD
RIVA-TADALAFIL
laboratoire riva inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
87569011bf650e39
Company
laboratoire riva inc.
Type
Standard
Approval Details
Approval Id
87569011bf650e39
Drug Approval Canada Name
RIVA-TADALAFIL
Product Name
RIVA-TADALAFIL
Status
Marketed
Status Date
2022-11-25
Original Market Date
2016-07-13
Din
02454742
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:12.12
Atc Original
G04BE08 TADALAFIL
Atc Name
g 04 be 08
Aig Number
0149485002
Company Name
laboratoire riva inc.
Company Address
660 Boul. Industriel, Blainville, Quebec, Canada, J7C 3V4
Active Ingredients
TADALAFIL
20 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
87569011bf650e39
Type
Standard
Back to Health Canada Approvals